Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark

[1]  K. Borch-Johnsen,et al.  The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population‐based screening study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[2]  K. Kosaka,et al.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.

[3]  Hideo Ayame,et al.  [The Da Qing IGT and Diabetes study]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[4]  K. Borch-Johnsen,et al.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms , 2004, Diabetologia.

[5]  Stephen W. Sorensen,et al.  Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis , 2004, Annals of Internal Medicine.

[6]  Bendix Carstensen,et al.  A Danish diabetes risk score for targeted screening: the Inter99 study. , 2004, Diabetes care.

[7]  T. Valle,et al.  Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[8]  S. Colagiuri,et al.  Comparability of venous and capillary glucose measurements in blood , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[9]  K. Borch-Johnsen,et al.  Screening for Type 2 diabetes—should it be now? , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[10]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[11]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[12]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[13]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[14]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[15]  Nicholas J Wareham,et al.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria , 2001, BMJ : British Medical Journal.

[16]  S. Keinänen-Kiukaanniemi,et al.  Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance. , 2000, Diabetes research and clinical practice.

[17]  T Lauritzen,et al.  The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening , 2000, International Journal of Obesity.

[18]  G. Riccardi,et al.  Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. , 1999, Diabetes care.

[19]  L. Bouter,et al.  The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study , 1998, Diabetes Care.

[20]  R. Bain,et al.  Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.

[21]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[22]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .